Both the novel NMR biomarker of inflammation, GlycA, and HS-CRP are independent and additive predictors of future cardiovascular events among patients undergoing coronary angiography: Results from the Intermountain Heart Collaborative Study

Muhlestein JB, May HT, Galenko O, et al.